Key result
iFR-guided deferral of coronary revascularization shows similar long-term MACE risk to FFR.
Why the study?
The study aimed to assess long-term outcomes in a large real-world population when coronary revascularization was deferred based on iFR versus FFR.
Does deferral of revascularization based on iFR compared to FFR reduce MACE in patients with coronary lesions?
Cohort (n=11,324)
Yes
Does deferral of revascularization based on iFR compared to FFR reduce MACE in patients with coronary lesions?
Effect estimate: HR 0.947 (95% CI 0.84-1.08)
Absolute Event Rate: 26.7% vs 25.9%
p-value: p=0.39
Deferral of coronary revascularization based on iFR shows similar long-term safety compared to FFR in a large real-world population.
Supports iFR deferral safety in routine care; extends observational data but leaves open need for randomized confirmation.
BackgroundDeferral of coronary revascularization is safe whether guided by instantaneous wave-free ratio (iFR) or by fractional flow reserve (FFR). We aimed to assess long-term outcomes in patients deferred from revascularization based on iFR or FFR in a large real-world population.MethodsFrom 2013 through 2017, 201,933 coronary angiographies were registered in the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). We included all patients (n = 11,324) with at least 1 coronary lesion deferred from PCI during an index procedure using iFR (>0.89; n = 1998) or FFR (>0.80; n = 9326). The primary outcome was major adverse cardiac events (MACE) defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization. A multivariable-adjusted Cox proportional hazards model was used, with analysis for interaction of prespecified subgroups.ResultsPatients presented with stable angina pectoris (iFR 46.9% vs FFR 48.6%), unstable angina or non–ST-elevation myocardial infarction (iFR 37.7% vs FFR 33.1%), ST-elevation myocardial infarction (iFR 1.9% vs FFR 1.6%), and other indications (iFR 12.5% vs FFR 15.7%). The median follow-up was 2 years for both iFR and FFR groups. At the conclusion of the study, the cumulative MACE risks were 26.7 for the iFR group and 25.9% for FFR group. In the adjusted analysis, no difference was found between the 2 groups (adjusted hazard ratio: iFR vs FFR, 0.947; 95% CI, 0.84-1.08; P = 39). Consistent with the overall findings, the prespecified subgroups showed no interaction with the FFR/iFR results.ConclusionsDeferral of revascularization showed similar long-term safety whether based on iFR or on FFR.
No takes yet. Share an insight, caveat, or question.
Yndigegn et al. (2023) conducted a cohort in Coronary artery disease (n=11,324). Deferral of revascularization based on iFR vs. Deferral of revascularization based on FFR was evaluated on Major adverse cardiac events (MACE) defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization (HR 0.947, 95% CI 0.84-1.08, p=0.39). Deferral of coronary revascularization based on iFR showed similar long-term MACE risk compared to FFR (26.7% vs 25.9%; HR 0.947; 95% CI 0.84-1.08).